Day: April 28, 2025

Appili Therapeutics Announces New Patents Granted for Commercial Stage Asset LIKMEZ®™

Written by Customer Service on April 28, 2025. Posted in Public Companies.

New patents provide additional composition of matter and methods of use claims, strengthening the protection for liquid oral taste-masked reformulation, LIKMEZ New subject matter listed in the U.S. Food and Drug Administration’s (“FDA”) Orange Book HALIFAX, Nova Scotia, April 28, 2025 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced the United States Patent and Trademark Office and the Mexican Patent Office have granted new patent claims protecting its oral formulation of metronidazole, LIKMEZ®™. The newly granted patents include:U.S. patent no. 20230086660A1 – Oral Formulations of Metronidazole and Methods of Treating an Infection...

Brødrene A & O Johansen A/S acquires leading e-commerce domain “VVS-eksperten.dk” with effect from 1 Januar 2026

Written by Customer Service on April 28, 2025. Posted in Public Companies.

Albertslund, 28th April 2025 Brødrene A & O Johansen A/S acquires leading e-commerce domain “VVS-eksperten.dk” with effect from 1 January 2026 Brødrene A & O Johansen A/S has today entered into an agreement to acquire the domain VVS-eksperten.dk, one of Denmark’s leading online platforms for plumbing and heating products. The acquisition further strengthens AO’s position in the Danish online market and complements the company’s already strong digital platform. VVS-eksperten.dk has established itself as a trusted destination for private consumers seeking a wide selection of plumbing and heating articles at competitive prices. The acquisition supports AO’s continued investment in digital growth and customer-centric online solutions. We look forward to continuing to service VVS-eksperten’s customers on a new VVS-eksperten.dk webshop...

Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium

Written by Customer Service on April 28, 2025. Posted in Public Companies.

MELBOURNE, Australia and SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer presented the ATH434-201 Phase 2 clinical trial results at the annual MSA Research Symposium hosted by University College London, Institute of Neurology in partnership with the MSA Trust of the U.K. “We were honoured to be selected to present the recent data from our double-blind Phase 2 trial,” said, Dr. Stamler. “The Symposium brought together prominent clinicians and researchers from both Europe and the US along with industry scientists, all of whom are focused on increasing their understanding of MSA and...

Kandi Technologies Reports 2024 Financial Results

Written by Customer Service on April 28, 2025. Posted in Earnings Releases And Operating Results.

Revenue Of $127.6M up 3.2% YoY, Supported by Expanded Product Reach And Improved Geographic Balance Electric Off-Road Vehicle Revenue Rose 8.9% YoY, Reinforcing Core Segment Leadership Enhanced Supply Chain Flexibility with Taiwan Upgrades, While Progressing Steadily Toward U.S. Localization GoalsJINHUA, China, April 28, 2025 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (the “Company”, “we” or “Kandi”) (NASDAQ GS: KNDI), today announced its financial results for the full year ended December 31, 2024. Full Year 2024 HighlightsTotal revenue increased to $127.6 million, a 3.2% increase from $123.6 million in 2023.By segment: Sales of off-road vehicles and associated parts rose 8.9% year-over-year to $116.6 million, accounting for over 91% of total annual revenue. By geography: Revenue from China grew 80% year-over-year,...

Cannara Biotech Delivers Record Q2 Results as National Expansion Accelerates

Written by Customer Service on April 28, 2025. Posted in Earnings Releases And Operating Results.

Record Revenue: Net revenues of $26.6 million in Q2 2025, a 35% increase compared to $19.7 million in Q2 2024, driven by national brand growth and product innovation. Record Profitability: Gross profit before fair value adjustments rose 52% to $10.8 million in Q2 2025 from $7.1 million in Q2 2024, with gross margins improving to 41%. Strong Adjusted EBITDA: Delivered sixteenth consecutive quarter of positive Adjusted EBITDA, more than doubling to a record $7.1 million, up 102% from Q2 20241. Expanding Market Presence: Increased national market share to 3.9% in Q2 2025, up 34.5% from same period of prior year, with notable share gains in Québec, Ontario, and Alberta2. Strategic Execution on Track: Achieving Fiscal 2025 objective of activating two new grow zones, with the first brought online in April and the second scheduled for May, bringing...

NANO Nuclear Announces Full Dismissal of Nevada Lawsuit

Written by Customer Service on April 28, 2025. Posted in Public Companies.

New York, N.Y., April 28, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that on Thursday, April 24, 2025, a Las Vegas judge granted in full two motions to dismiss brought by NANO Nuclear Energy Inc. and its officers and directors in a putative shareholder derivative action entitled Latza v. Walker, et al., Case No. A-24-900423-B, Clark County, Nevada District Court. “We are extremely pleased that this case has been so promptly adjudicated and dismissed in its entirety,” said Jay Yu, Founder and Chairman of NANO Nuclear. “This ruling will allow us to devote more of our time and attention to NANO Nuclear’s primary mission of becoming the leading commercially focused...

Green Thumb to Open RISE Dispensary Ocala in Florida, its 104th Retail Location in the Nation, on April 29

Written by Customer Service on April 28, 2025. Posted in Public Companies.

CHICAGO and VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) — RISE Dispensaries, a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced that RISE Dispensary Ocala, the Company’s 22nd retail location in Florida and 104th nationwide, will open on April 29. Located at 3873 SW College Road, the dispensary will offer medical patients a diverse collection of cannabis products from brands including RYTHM, Dogwalkers, &Shine, Good Green, and Doctor Solomon’s. As part of RISE and Green Thumb’s ongoing commitment to supporting local communities, RISE Dispensary Ocala will donate a portion of one day’s profits to community-based organization The Bridge 4 Veterans. “We are thrilled to open our first RISE Dispensary in...

Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa

Written by Customer Service on April 28, 2025. Posted in Public Companies.

VYJUVEK approved for the treatment of DEB from birth in Europe Approval allows for dosing at home or in a healthcare setting, as well as patient or caregiver administration if deemed appropriate by a healthcare professional PITTSBURGH, April 28, 2025 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that on April 23, 2025, the European Commission (EC) granted marketing authorization to VYJUVEK® (beremagene geperpavec-svdt) for the treatment of wounds in patients with dystrophic epidermolysis bullosa (DEB) who have mutations in the collagen type VII alpha 1 chain (COL7A1) gene, starting from birth. VYJUVEK is designed to address the genetic root cause of DEB by delivering functional copies of the human COL7A1 gene to provide wound healing and sustained functional type VII collagen protein expression...

Matador Technologies Inc. Announces Symbol Change and DTC Eligibility of its Common Shares

Written by Customer Service on April 28, 2025. Posted in Public Companies.

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) — Matador Technologies Inc. (“Matador” or the “Company”) (TSXV: MATA, OTCQB: MATAF), a Bitcoin Ecosystem company, is pleased to announce that the Company’s stock ticker symbol on the OTCQB Venture Market (the “OTCQB”) will change from “MTDTF” to “MATAF” effective as of market open on Monday, April 28, 2025. As a result of this change, “MATAF” will now be the ticker symbol for Matador’s common shares listed on the OTCQB. The change allows for improved and synchronized brand alignment for the stock and the Company. No action is required by Matador’s shareholders in connection with the ticker symbol change. Matador is also pleased to announce that its common shares, traded in the United States under the symbol “MATAF” on the OTCQB, are now eligible for electronic clearing and settlement through...

Clear Blue Technologies International to provide Corporate Update and Report Fiscal 2024 Financial Results and Host Conference Call on Thursday, May 1st, 2025

Written by Customer Service on April 28, 2025. Posted in Public Companies.

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) — Clear Blue Technologies International Inc. (TSXV: CBLU) the Smart Off-Grid™ Company, today announces that it will provide a corporate update and also report financial results for its fiscal 2024 on Wednesday, April 30, 2025, after the market closes. Welcome to Clear Blue 2.0! Clear Blue has successfully completed its financial restructuring and is now positioned to move forward and execute on the opportunity ahead. The Company has been very busy. Clear Blue will host a conference call on Thursday, May 1st, at 11:00 a.m. Eastern Time, to review the financial restructuring, the Company’s 2024 results, and to provide an update on its 2025 outlook and growth plan going forward. Those interested can register at: Registration Link https://us06web.zoom.us/webinar/register/WN_yLCwKEZnTLKhrAlYtqG51g Final...

Day: April 28, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals